As MYC, NFKB, and EZH2 are key transcriptional factors and epigenetic regulators in tumorigenesis [27–29], our data suggest that PARP10 could be involved in transcription and epigenomic regulation in AML. This evidence concerns the gene NFKB1 and acute myeloid leukemia.